What Brown Saw and You Can Too

A discussion of Robert Brown’s original observations of particles ejected by pollen of the plant Clarkia pulchella undergoing what is now called Brownian motion is given. We consider the nature of those particles and how he misinterpreted the Airy disk of the smallest particles to be universal organic building blocks. Relevant qualitative and quantitative investigations with a modern microscope and with a “homemade” single lens microscope similar to Brown’s are presented

What Brown saw and you can too

A discussion is given of Robert Brown's original observations of particles ejected by pollen of the plant \textit{Clarkia pulchella} undergoing what is now called Brownian motion. We consider the nature of those particles, and how he misinterpreted the Airy disc of the smallest particles to be universal organic building blocks. Relevant qualitative and quantitative investigations with a modern microscope and with a "homemade" single lens microscope similar to Brown's, are presented.Comment: 14.1 pages, 11 figures, to be published in the American Journal of Physics. This differs from the previous version only in the web site referred to in reference 3. Today, this Brownian motion web site was launched, and http://physerver.hamilton.edu/Research/Brownian/index.html, is now correc

Science Frontiers In Galaxy Evolution: Deep-Wide Surveys

Astro2010: The Astronomy and Astrophysics Decadal Survey : Science White Papers no 79. Available online : http://www8.nationalacademies.org/astro2010/DetailFileDisplay.aspx?id=24

Large Synoptic Survey Telescope Galaxies Science Roadmap

The Large Synoptic Survey Telescope (LSST) will enable revolutionary studies of galaxies, dark matter, and black holes over cosmic time. The LSST Galaxies Science Collaboration has identified a host of preparatory research tasks required to leverage fully the LSST dataset for extragalactic science beyond the study of dark energy. This Galaxies Science Roadmap provides a brief introduction to critical extragalactic science to be conducted ahead of LSST operations, and a detailed list of preparatory science tasks including the motivation, activities, and deliverables associated with each. The Galaxies Science Roadmap will serve as a guiding document for researchers interested in conducting extragalactic science in anticipation of the forthcoming LSST era

Effect of angiotensin-converting enzyme inhibitor and angiotensin receptor blocker initiation on organ support-free days in patients hospitalized with COVID-19

IMPORTANCE Overactivation of the renin-angiotensin system (RAS) may contribute to poor clinical outcomes in patients with COVID-19. Objective To determine whether angiotensin-converting enzyme (ACE) inhibitor or angiotensin receptor blocker (ARB) initiation improves outcomes in patients hospitalized for COVID-19. DESIGN, SETTING, AND PARTICIPANTS In an ongoing, adaptive platform randomized clinical trial, 721 critically ill and 58 non–critically ill hospitalized adults were randomized to receive an RAS inhibitor or control between March 16, 2021, and February 25, 2022, at 69 sites in 7 countries (final follow-up on June 1, 2022). INTERVENTIONS Patients were randomized to receive open-label initiation of an ACE inhibitor (n = 257), ARB (n = 248), ARB in combination with DMX-200 (a chemokine receptor-2 inhibitor; n = 10), or no RAS inhibitor (control; n = 264) for up to 10 days. MAIN OUTCOMES AND MEASURES The primary outcome was organ support–free days, a composite of hospital survival and days alive without cardiovascular or respiratory organ support through 21 days. The primary analysis was a bayesian cumulative logistic model. Odds ratios (ORs) greater than 1 represent improved outcomes. RESULTS On February 25, 2022, enrollment was discontinued due to safety concerns. Among 679 critically ill patients with available primary outcome data, the median age was 56 years and 239 participants (35.2%) were women. Median (IQR) organ support–free days among critically ill patients was 10 (–1 to 16) in the ACE inhibitor group (n = 231), 8 (–1 to 17) in the ARB group (n = 217), and 12 (0 to 17) in the control group (n = 231) (median adjusted odds ratios of 0.77 [95% bayesian credible interval, 0.58-1.06] for improvement for ACE inhibitor and 0.76 [95% credible interval, 0.56-1.05] for ARB compared with control). The posterior probabilities that ACE inhibitors and ARBs worsened organ support–free days compared with control were 94.9% and 95.4%, respectively. Hospital survival occurred in 166 of 231 critically ill participants (71.9%) in the ACE inhibitor group, 152 of 217 (70.0%) in the ARB group, and 182 of 231 (78.8%) in the control group (posterior probabilities that ACE inhibitor and ARB worsened hospital survival compared with control were 95.3% and 98.1%, respectively). CONCLUSIONS AND RELEVANCE In this trial, among critically ill adults with COVID-19, initiation of an ACE inhibitor or ARB did not improve, and likely worsened, clinical outcomes. TRIAL REGISTRATION ClinicalTrials.gov Identifier: NCT0273570

The evaluation of Pedilanthus palmeri Millsp. as a potential interior landscape plant

Pedilanthus palmeri Millsp. was evaluated as a potential interior landscaping plant. The optimal propagation technique, production and post-production light requirements, growth regulator response and photoperiod requirement were analyzed. Cuttings were successfully rooted within five weeks after treatment with aqueous solutions of IBA. Root fresh weight increased from 0.58 g with 0 mg·liter⁻¹ IBA to 1.12 g with 6736 mg·liter⁻¹ IBA. No difference in leaf length, width or thickness, plant height or node number was found between plants grown under 77% and 88% shade. Plants moved to a low light interior environment continued to grow and new, thin leaves replaced abscised leaves. The optimum concentration of the growth retardant Bonzi (paclobutrazol), 0.125 g ai per pot, caused a 46% reduction in shoot height. Apical pinching and 500 mg·liter-1 BA increased branch number 3.8-fold. Pedilanthus palmeri is a short day plant. Flowering occurred in the 8 and 10 hour light treatments but not in the longer photoperiods

If You Can\u27t Build It, They Won\u27t Come: Condominium Construction Moratoria and Gentrification

The increasing presence of bright, new condominium development in America’s cities is changing the composition and appearance of these urban landscapes. Long-time local residents in gentrifying areas are confronted daily with the impacts of development, and are searching for tools to preserve their communities and keep them affordable. One response has been proposed moratoria on condominium construction. This approach aims to stop the influx of more affluent individuals into urban neighborhoods by preventing the construction of higher-end condominiums. This Note examines the validity of such moratoria on condominium construction as an exercise of the police power. Through a comparison to rent control ordinances and condominium conversion moratoria, it argues that valid condominium construction moratoria can be implemented to address social and economic concerns. The Note concludes, however, that valid construction moratoria are not always the most appropriate or effective growth management tool to address a gentrifying community’s needs